Blue Bell, PA, United States of America

Mahdieh Yazdani

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahdieh Yazdani. Retrieved from https://idiyas.com/inventor/mahdieh-yazdani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mahdieh Yazdani: Innovator in Respiratory Virus Treatment

Introduction

Mahdieh Yazdani is an accomplished inventor based in Blue Bell, PA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for respiratory viruses.

Latest Patents

Yazdani holds a patent for "Inhibitors of human respiratory syncytial virus and metapneumovirus." This patent focuses on compounds of Formula I or a pharmaceutically acceptable salt thereof, aimed at treating human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV). Her innovative work in this area is crucial for advancing therapeutic options for these viral infections.

Career Highlights

Currently, Mahdieh Yazdani is employed at Merck Sharp & Dohme LLC, a leading global healthcare company. Her role involves research and development in the pharmaceutical sector, where she applies her expertise to create effective treatments.

Collaborations

Yazdani collaborates with notable colleagues, including Douglas C. Beshore and Kira A. Armacost. These partnerships enhance her research efforts and contribute to the advancement of medical science.

Conclusion

Mahdieh Yazdani's work exemplifies the impact of innovation in healthcare, particularly in combating respiratory viruses. Her contributions are vital for improving patient outcomes and advancing medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…